id	keyword
cblr-1794	note
cblr-1794	supra
cblr-1794	supra note
cblr-1794	biosimilar
cblr-1794	drug
cblr-1794	bpcia
cblr-1794	biologics
cblr-1794	fda
cblr-1794	exclusivity
cblr-1794	product
cblr-1794	generic
cblr-1794	market
cblr-1794	reference
cblr-1794	act
cblr-1794	period
cblr-1794	ftc
cblr-1794	price
cblr-1794	approval